Sheynaz Bassa, MD, ChB Headshot

Sheynaz Bassa, MD, ChB

University of Pretoria
Pretoria, Gauteng

Name: Dr. Sheynaz Bassa
Degrees: MBChB, FC Rad Onc (SA)
Institution: University of Pretoria, Steve Biko Academic Hospital
City: Pretoria, South Africa


Dr. Sheynaz Bassa is a board-certified radiation oncologist and the Head of the Department of Radiation Oncology at the University of Pretoria and Steve Biko Academic Hospital in Pretoria, South Africa. She holds an MBChB from the University of KwaZulu-Natal and completed her specialist training in Radiation Oncology at the University of the Witwatersrand.


Dr. Bassa has held both clinical and academic leadership roles across the public and private sectors. Since 2019, she has led the department at Steve Biko Academic Hospital, where she oversees postgraduate training and service delivery. Her clinical and research focus lies in gynecologic oncology, with particular expertise in brachytherapy, radiotherapy planning, and protocol development tailored to low- and middle-income settings.


She is a dedicated mentor to postgraduate students and junior faculty, fostering capacity building in clinical oncology and academic research. Dr. Bassa is an active member of the College of Radiation Oncologists and the Colleges of Medicine of South Africa (CMSA), contributing to national curriculum development, guideline formulation, and examination processes.

Disclosures:

  • Employment: University of Pretoria, Steve Biko Academic Hospital:Head of Department Radiation Oncology:Employee
  • Compensation: MSD: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Education Meeting Faculty, Speaker's Bureau, Honoraria, Travel Expenses-End Date: Present ;Astellas: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 2024/09/07 ;Janssen Pharmaceuticals: Education Meeting Faculty, Speaker's Bureau, Honoraria, Travel Expenses-End Date: ongoing ;Astrazenca: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 2024/08/18 ;Interna
  • Ownership: none
  • Leadership: none